Literature DB >> 10360382

Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1.

D Metcalf1, W S Alexander, A G Elefanty, N A Nicola, D J Hilton, R Starr, S Mifsud, L Di Rago.   

Abstract

Mice with homozygous inactivation of the gene encoding the suppressor of cytokine signaling-1 (SOCS-1) protein die within 21 days of birth with low body weight, fatty degeneration and necrosis of the liver, infiltration of the lung, pancreas, heart and skin by macrophages and granulocytes and a profound depletion of T- and B-lymphocytes. In the present study, SOCS-1 -/- mice were found to have a moderate neutrophilia, and reduced platelet and hematocrit levels. Replacement of the SOCS-1 gene by a lac-Z reporter gene allowed documentation by FACS sorting that at least a proportion of granulocyte-macrophage progenitor cells transcribe SOCS-1. Most hematopoietic progenitor cell frequencies were normal in -/- marrow as were the size and cellular content of colonies formed by -/- progenitor cells in response to various stimulating factors. However, there was an increased frequency of macrophage progenitor cells in -/- mice and, abnormally, one quarter of all progenitor cells were located in the liver. Progenitor cells from -/- mice were hyper-responsive to stimulation by GM-CSF but not by M-CSF or Multi-CSF (IL-3). Progenitor cells from -/- mice were also hypersensitive to inhibition by interferon-gamma (IFN-gamma), the degree of inhibition varying markedly with the stimulating factor used. The suppressive effects of IFN-gamma therefore appear to involve interactions with particular growth factor-initiated signals in -/- cells--interactions that are strongly modulated by the action of the SOCS-1 protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360382     DOI: 10.1038/sj.leu.2401440

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  15 in total

1.  Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1.

Authors:  Daniela Ungureanu; Pipsa Saharinen; Ilkka Junttila; Douglas J Hilton; Olli Silvennoinen
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

2.  The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-gamma and lacking the SOCS-1 gene.

Authors:  D Metcalf; L Di Rago; S Mifsud; L Hartley; W S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

3.  Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signaling.

Authors:  Chulbul M I Ahmed; Rea Dabelic; James P Martin; Lindsey D Jager; S Mohammad Haider; Howard M Johnson
Journal:  J Immunol       Date:  2010-06-11       Impact factor: 5.422

4.  Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 Are Stimulated within the Eye during Experimental Murine Cytomegalovirus Retinitis in Mice with Retrovirus-Induced Immunosuppression.

Authors:  Hsin Chien; Christine I Alston; Richard D Dix
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

5.  The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors.

Authors:  Q Pang; S Fagerlie; T A Christianson; W Keeble; G Faulkner; J Diaz; R K Rathbun; G C Bagby
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

6.  Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis.

Authors:  Anupama Narla; Shilpee Dutt; J Randall McAuley; Fatima Al-Shahrour; Slater Hurst; Marie McConkey; Donna Neuberg; Benjamin L Ebert
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

7.  Differential expression and potential role of SOCS1 and SOCS3 in Wallerian degeneration in injured peripheral nerve.

Authors:  Elizabeth I Girolami; Delphine Bouhy; Michael Haber; Howard Johnson; Samuel David
Journal:  Exp Neurol       Date:  2009-07-02       Impact factor: 5.330

8.  Differential regulation of SOCS genes in normal and transformed erythroid cells.

Authors:  Mohinder K Sarna; Evan Ingley; Samantha J Busfield; Vanessa S Cull; Winald Lepere; David J McCarthy; Michael J Wright; Gene A Palmer; David Chappell; Melissa S Sayer; Warren S Alexander; Douglas J Hilton; Robyn Starr; Stephanie S Watowich; Thomas Bittorf; S Peter Klinken; Peta A Tilbrook
Journal:  Oncogene       Date:  2003-05-22       Impact factor: 9.867

Review 9.  Targeting GM-CSF in inflammatory diseases.

Authors:  Ian P Wicks; Andrew W Roberts
Journal:  Nat Rev Rheumatol       Date:  2015-12-03       Impact factor: 20.543

10.  Role of suppressor of cytokine signaling-1 in murine atherosclerosis.

Authors:  Christina Grothusen; Harald Schuett; Anja Hillmer; Stefan Lumpe; Karsten Grote; Matthias Ballmaier; Andre Bleich; Silke Glage; Uwe J F Tietge; Maren Luchtefeld; Bernhard Schieffer
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.